Inventor · disambiguated record
Rachel Kent
Also filed as: KENT RACHEL · KENT RACHEL B · KENT RACHEL BARIBAULT
15 granted patents·10 pending applications·14,920 citations·filing 1989–2024
97Inventor score
Top patents by PatentIndex Score
25 records- 0198US5571698ADirected evolution of novel binding proteinsPROTEIN ENG CORP·Filed 1993·Granted Nov 5, 1996·2.7k cites·83 claims
- 0298US5403484AViruses expressing chimeric binding proteinsPROTEIN ENG CORP·Filed 1993·Granted Apr 4, 1995·2.9k cites·49 claims
- 0398US5223409ADirected evolution of novel binding proteinsPROTEIN ENG CORP·Filed 1991·Granted Jun 29, 1993·6.9k cites·66 claims
- 0497US5837500ADirected evolution of novel binding proteinsDYAX CORP·Filed 1995·Granted Nov 17, 1998·595 cites·43 claims
- 0597US5663143AEngineered human-derived kunitz domains that inhibit human neutrophil elastaseDYAX CORP·Filed 1994·Granted Sep 2, 1997·272 cites·9 claims
- 0697US5198346AGeneration and selection of novel DNA-binding proteins and polypeptidesPROTEIN ENG CORP·Filed 1990·Granted Mar 30, 1993·606 cites·48 claims
- 0797US5096815AGeneration and selection of novel dna-binding proteins and polypeptidesPROTEIN ENG CORP·Filed 1989·Granted Mar 17, 1992·663 cites·42 claims
- 0895US7208293B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2001·Granted Apr 24, 2007·94 cites·13 claims
- 0995US7118879B2Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target materialDYAX CORP·Filed 2002·Granted Oct 10, 2006·80 cites·26 claims
- 1094US6979538B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2001·Granted Dec 27, 2005·80 cites·19 claims
- 1193US7893007B2Directed evolution of novel binding proteinsDYAX CORP·Filed 2008·Granted Feb 22, 2011·22 cites·19 claims
- 1293US7413537B2Directed evolution of disulfide-bonded micro-proteinsDYAX CORP·Filed 2002·Granted Aug 19, 2008·40 cites·34 claims
- 1391US7078383B2ITI-D1 Kunitz domain mutants as HNE inhibitorsDYAX CORP·Filed 2002·Granted Jul 18, 2006·28 cites·10 claims
- 1490US2025066488A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 1588US8765385B2Method of detection of neutralizing anti-actriib antibodiesKUMAR RAVINDRA·Filed 2011·Granted Jul 1, 2014·15 cites·8 claims
- 1685US9624301B2Polynucleotides encoding an actriib antibodyACCELERON PHARMA INC·Filed 2016·Granted Apr 18, 2017·3 cites·4 claims
- 1776US2022098309A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2021·Application pending·0 cites
- 1866US2019023797A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2018·Application pending·0 cites
- 1965US2015030606A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2014·Application pending·0 cites
- 2062US2018051088A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2017·Application pending·0 cites
- 2161US2013189269A1Actriib binding agents and uses thereofACCELERON PHARMA INC·Filed 2013·Application pending·0 cites
- 2258US2007259417A1Directed evolution of novel binding proteinsDYAX CORP·Filed 2007·Application pending·0 cites
- 2353US2006134087A1ITI-D1 Kunitz domain mutants as hNE inhibitorsDYAX CORP·Filed 2005·Application pending·0 cites
- 2451US2004110933A1CD44-binding ligandsDYAX CORP·Filed 2003·Application pending·0 cites
- 2549US2003223977A1Kunitz domain mutants as cathepsin G inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rachel Kent files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →